금연 및 니코틴 중독 치료 시장(2026-2030년)

The global smoking cessation and nicotine de-addiction market is forecasted to grow by USD 59653.9 mn during 2025-2030, accelerating at a CAGR of 18.6% during the forecast period. The report on the global smoking cessation and nicotine de-addiction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancement and digital health integration, expansion of public health support and government funding, enhanced distribution networks and product availability.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global smoking cessation and nicotine de-addiction market is segmented as below:

By Distribution Channel

• Drug stores and retailers
• Hospital pharmacies
• Online retail

By Product

• E-cigarette
• NRT
• Drug therapy

By Route Of Administration

• Gum
• Transdermal
• Inhaler
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the emergence of plant based and botanical cessation solutions as one of the prime reasons driving the global smoking cessation and nicotine de-addiction market growth during the next few years. Also, adoption of precision medicine and genetic personalization and integration of behavioral economics and gamification will lead to sizable demand in the market.

The report on the global smoking cessation and nicotine de-addiction market covers the following areas:

• Global smoking cessation and nicotine de-addiction market sizing
• Global smoking cessation and nicotine de-addiction market forecast
• Global smoking cessation and nicotine de-addiction market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global smoking cessation and nicotine de-addiction market vendors that include Alchem International Pvt. Ltd, Alkalon AS, British American Tobacco Plc, Cambrex Corp., Cipla Inc., Dr. Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Haleon Plc, Imperial Brands Plc, Kenvue Inc., Medline Inc., Perrigo Co. Plc, Pfizer Inc., Philip Morris International, Qnovia, Strides Pharma Ltd., Zonnic. Also, the global smoking cessation and nicotine de-addiction market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Smoking Cessation And Nicotine De-Addiction Market 2020 - 2024
  • Historic Market Size - Data Table on Global Smoking Cessation And Nicotine De-Addiction Market 2020 - 2024 ($ million)
• 5.2 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 Route of Administration segment analysis 2020 - 2024
  • Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Smoking Cessation and Nicotine De-addiction Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Distribution Channel

• 8.1 Market segments
• 8.2 Comparison by Distribution Channel
• 8.3 Drug stores and retailers - Market size and forecast 2025-2030
• 8.4 Hospital pharmacies - Market size and forecast 2025-2030
• 8.5 Online retail - Market size and forecast 2025-2030
• 8.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 E-cigarette - Market size and forecast 2025-2030
• 9.4 NRT - Market size and forecast 2025-2030
• 9.5 Drug therapy - Market size and forecast 2025-2030
• 9.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by Route of Administration

• 10.1 Market segments
• 10.2 Comparison by Route of Administration
• 10.3 Gum - Market size and forecast 2025-2030
• 10.4 Transdermal - Market size and forecast 2025-2030
• 10.5 Inhaler - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 South Africa - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 Argentina - Market size and forecast 2025-2030
  • 12.6.5 UAE - Market size and forecast 2025-2030
  • 12.6.6 Israel - Market size and forecast 2025-2030
  • 12.6.7 Turkey - Market size and forecast 2025-2030
  • 12.6.8 Colombia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Technological advancement and digital health integration
  • Expansion of public health support and government funding
  • Enhanced distribution networks and product availability
• 13.2 Market challenges
  • Regulatory frameworks and compliance burdens
  • Economic constraints and research expenditure
  • Socio cultural stigma and behavioral barriers
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Emergence of plant based and botanical cessation solutions
  • Adoption of precision medicine and genetic personalization
  • Integration of behavioral economics and gamification

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Alchem International Pvt. Ltd
  • Alchem International Pvt. Ltd - Overview
  • Alchem International Pvt. Ltd - Product / Service
  • Alchem International Pvt. Ltd - Key offerings
  • SWOT
• 15.5 Alkalon AS
  • Alkalon AS - Overview
  • Alkalon AS - Product / Service
  • Alkalon AS - Key offerings
  • SWOT
• 15.6 British American Tobacco Plc
  • British American Tobacco Plc - Overview
  • British American Tobacco Plc - Business segments
  • British American Tobacco Plc - Key offerings
  • British American Tobacco Plc - Segment focus
  • SWOT
• 15.7 Cambrex Corp.
  • Cambrex Corp. - Overview
  • Cambrex Corp. - Product / Service
  • Cambrex Corp. - Key offerings
  • SWOT
• 15.8 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
• 15.9 Dr. Reddys Laboratories Ltd.
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key news
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • SWOT
• 15.10 Glenmark Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd. - Overview
  • Glenmark Pharmaceuticals Ltd. - Product / Service
  • Glenmark Pharmaceuticals Ltd. - Key offerings
  • SWOT
• 15.11 Haleon Plc
  • Haleon Plc - Overview
  • Haleon Plc - Business segments
  • Haleon Plc - Key offerings
  • Haleon Plc - Segment focus
  • SWOT
• 15.12 Imperial Brands Plc
  • Imperial Brands Plc - Overview
  • Imperial Brands Plc - Business segments
  • Imperial Brands Plc - Key offerings
  • Imperial Brands Plc - Segment focus
  • SWOT
• 15.13 Kenvue Inc.
  • Kenvue Inc. - Overview
  • Kenvue Inc. - Business segments
  • Kenvue Inc. - Key news
  • Kenvue Inc. - Key offerings
  • Kenvue Inc. - Segment focus
  • SWOT
• 15.14 Medline Inc.
  • Medline Inc. - Overview
  • Medline Inc. - Product / Service
  • Medline Inc. - Key offerings
  • SWOT
• 15.15 Perrigo Co. Plc
  • Perrigo Co. Plc - Overview
  • Perrigo Co. Plc - Business segments
  • Perrigo Co. Plc - Key offerings
  • Perrigo Co. Plc - Segment focus
  • SWOT
• 15.16 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 15.17 Philip Morris International
  • Philip Morris International - Overview
  • Philip Morris International - Business segments
  • Philip Morris International - Key offerings
  • Philip Morris International - Segment focus
  • SWOT
• 15.18 Strides Pharma Ltd.
  • Strides Pharma Ltd. - Overview
  • Strides Pharma Ltd. - Product / Service
  • Strides Pharma Ltd. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations